Celltrion | 068270 - Cash And Equivalent

Stock Price
202,000.00
Daily Change
8,300.00 4.29%
Monthly
-0.98%
Yearly
30.74%
Q2 Forecast
184,597.56

Celltrion reported KRW29.65B in Cash and Equivalent for its fiscal quarter ending in June of 2025.





Cash And Equivalent Change Date
Akebia Therapeutics USD 184.84M 18.4M Dec/2025
Alaunos Therapeutics USD 1.94M 941K Sep/2025
Avita Medical AUD 10.24M 1.98M Dec/2025
Celltrion KRW 29.65B 799.42B Jun/2025
Dianthus Therapeutics USD 51.09M 4.9M Dec/2025
Ionis Pharmaceuticals USD 2.68B 437M Dec/2025
IQVIA Holdings USD 1.98B 166M Dec/2025
Moderna USD 2.6B 1.46B Dec/2025
Organon & Co USD 672M 73M Sep/2025
Revvity USD 919.86M 11.53M Dec/2025
Tectonic Therapeutic USD 253.8M 14.64M Dec/2025
Viatris USD 1.32B 347.1M Dec/2025
Xeris Pharmaceuticals USD 111.04M 19.44M Dec/2025